Abstract:Background: The development of drug resistance and the persistence of leukemia stem cells are major obstacles for the use of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML). The induction of autophagic death in tumor cells represents a new route for leukemia treatment. Our previous study showed that infection of CML cells with oncolytic viruses carrying the autophagy gene Beclin1 downregulated BCR/ABL protein expression and significantly increased the killing effect of the oncolytic viruses on CML cells via autophagy activation. However, the specific molecular mechanisms underlying the regulation of BCR/ABL and Beclin1-dependent CML cell killing remain unclear. Methods: A physical interaction between BCR/ABL and Beclin1 was characterized via GST-pulldown, co-IP and dual-luciferase reporter assays. Cell proliferation was examined via CCK-8 and clone formation assays. The expression levels of the related proteins were measured via Western blotting. Autophagosomes were observed under transmission electron microscopy. Lentiviral vectors carrying Atg7/UVRAG shRNA or the Beclin1 gene were used to modulate the expression levels of the indicated genes. Immunofluorescence were performed to examine colocalization of BCR/ABL and p62/SQSTM1. CD34(+)CD38(-) cells were isolated from bone marrow samples from CML patients via fluorescence-activated cell sorting. Results: In this study, we observed that Beclin1 directly interacts with BCR/ABL. Beclin1 inhibited the activity of the BCR/ABL promoter to downregulate the level of BCR/ABL protein and to promote the downstream colocalization of p62/SQSTM1 and BCR/ABL to autolysosomes for degradation via activation of the autophagy signaling pathway. In CML cell lines, primary cells and CD34(+)CD38(-) leukemia stem cells, Beclin1 overexpression significantly inhibited cell growth and proliferation and induced autophagy. Conclusion: Taken together, our results suggest that autophagy induction via Beclin1 overexpression might offer new approaches for treating TKI-resistant CML and for promoting the clearance of leukemia stem cells, both of which have important clinical implications.

Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor

Autophagy-Related Beclin 1 and Head and Neck Cancers

Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin

Beclin 2 negatively regulates innate immune signaling and tumor development

Mammalian Mst1 And Mst2 Kinases Play Essential Roles In Organ Size Control And Tumor Suppression

Beclin 1, an Autophagy-Related Gene, Augments Apoptosis in U87 Glioblastoma Cells

Knockdown of Beclin-1 Impairs Epithelial-Mesenchymal Transition of Colon Cancer Cells.

Beclin1 is essential for the pancreas development

BAC-mediated transgenic expression of fluorescent autophagic protein Beclin 1 reveals a role for Beclin 1 in lymphocyte development

Beclin 1 regulates recycling endosome and is required for skin development in mice

Polo-like kinase 1 is essential for early embryonic development and tumor suppression.

Research progress of Beclin1 and Cancer

Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy

Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy.

Beclin 1 Deficiency Causes Hepatic Cell Apoptosis Via Endoplasmic Reticulum Stress in Zebrafish Larvae

The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy

Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity

Aurora A Is Essential for Early Embryonic Development and Tumor Suppression

Genetic and Epigenetic Silencing of the Beclin 1 Gene in Sporadic Breast Tumors

Beclin 1 Biology And Its Role In Heart Disease